Peptide Bremelanotide PT-141 (10mg/vial) CAS NO.32780-32-8 CAS NO.32780-32-8

Basic Information:
Product Name: PT-141
CAS:  32780-32-8
MF:   C50H68N14O10
MW:   1025.2
Single Impurity (HPLC):   1.0%max
Amino Acid Composition:   About 10% of theoretical
Peptide Content (N%):   80.0% min.
Water Content(Karl Fischer):   6.0%max.
Acetate Content (HPIC):   15.0%max.
Appearance: White powder


Description:
PT-141 is the first of a new class of drugs called melanocortin agonists being developed to treat sexual dysfunction. The mechanism of action of PT-141 may offer significant safety and efficacy benefits over currently available products because it acts on the pathway that controls sexual function without acting directly on the vascular system. 
 

Function:

PT-141 was developed from the Melanotan 2 Peptide, which underwent testing as a sunless tanning agent. In initial testing, Melanotan 2 did induce tanning, but additionally caused sexual arousal and spontaneous erections as unexpected side effects in nine out of the ten original male volunteer test subjects. Palatin completed patient treatment in its Phase 2B clinical trial in premenopausal women with FSD Primary data analysis and announcement of top-line results anticipated in first-half of fourth quarter of calendar year 2012. In studies, PT-141 was shown to be effective in treating sexual dysfunction in both men (erectile dysfunction or impotence) and women (sexual arousal disorder). 
 
PT-141 is a synthetic amino acid protein discovered during clinical trials using the Melanotan 2 for sunless tanning, photo-protection results from melanotans. Participants were documented as having experienced aphrodisiac reactions, leading to the further developmentPT-141. The melanocortin system targets receptors associated with desire through the melanocyte stimulating hormone paths that cross the blood-brain-barrier. Potentially the powerful sex-drug results feeling an aphrodisiac experience amplifying arousal pt141 reviews have shown the ability to increase libido effects of both men and women.